American Psychiatric Association Diagnostic and statistical manual of mental disorders. 5th ed. APA Publishing, Washington

Somatoforme Störungen: Diagnostik, Konzepte und Therapie bei Körpersymptomen ohne Organbefund.

Springer, ()

From conversion hysteria to somatisation to abnormal illness behaviour?.

J Psychosom Res. 40: 345-350

Somatoforme Störungen.

Nervenarzt. 72: 487-500Spiegel D. Loewenstein R.J. Lewis-Fernández R. et al.

Dissociative disorders in DSM-5.

Depress Anxiety. 28: 824-852American Psychiatric Association Diagnostic and statistical manual of mental disorders. 4th Ed. APA Publishing, WashingtonNewby J.M. Hobbs M.J. Mahoney A.E.J. et al.

DSM-5 illness anxiety disorder and somatic symptom disorder: Comorbidity, correlates, and overlap with DSM-IV hypochondriasis.

J Psychosom Res. 101: 31-37

How to use the new DSM-5 somatic symptom disorder diagnosis in research and practice: a critical evaluation and a proposal for modifications.

Annu Rev Clin Psychol. 10: 339-367Toussaint A. Hüsing P. Kohlmann S. et al.

Excessiveness in symptom-related thoughts, feelings, and behaviors: an investigation of somatic symptom disorders in the general population.

Psychosom Med. 83: 164-170Kotov R. Krueger R.F. Watson D. et al.

The hierarchical taxonomy of psychopathology (HiTOP): a dimensional alternative to traditional nosologies.

J Abnorm Psychol. 126: 454-477Krueger R.F. Chentsova-Dutton Y.E. Markon K.E. et al.

A cross-cultural study of the structure of comorbidity among common psychopathological syndromes in the general health care setting.

J Abnorm Psychol. 112: 437-447Watson D. Levin-Aspenson H.F. Waszczuk M.A. et al.

Validity and utility of hierarchical taxonomy of psychopathology (HiTOP): III. Emotional dysfunction superspectrum.

World Psychiatr. 21: 26-54Hiller W. Rief W. Brähler E.

Somatization in the population: from mild bodily misperceptions to disabling symptoms.

Soc Psychiatry Psychiatr Epidemiol. 41: 704-712Jacobi F. Wittchen H.-U. Hölting C. et al.

Prevalence, co-morbidity and correlates of mental disorders in the general population: Results from the German health interview and examination survey (GHS).

Psychol Med. 34: 597-611Noyes R. Carney C.P. Hillis S.L. et al.

Prevalence and correlates of illness worry in the general population.

Psychosomatics. 46: 529-539Weck F. Richtberg S. Neng J.

Epidemiology of hypochondriasis and health anxiety: Comparison of different diagnostic criteria.

Curr Psychiatry Rev. 10: 14-23

A systematic review of the epidemiology of somatisation disorder and hypochondriasis.

J Psychosom Res. 56: 391-408Behm A.C. Hüsing P. Löwe B. et al.

Persistence rate of DSM-5 somatic symptom disorder: 4-year follow-up in patients from a psychosomatic outpatient clinic.

Compr Psychiatry. 110: 152265Löwe B. Levenson J. Depping M. et al.

Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis.

Psychol Med. 52: 632-648Bailer J. Kerstner T. Witthöft M. et al.

Health anxiety and hypochondriasis in the light of DSM-5.

Hist Philos Logic. 29: 219-239First M.B. Williams J.B.W. Karg R.S. Structured clinical interview for DSM-5(R) disorders - clinician version (SCID-5-CV). APA Publisher, ArlingtonJiang Y. Wei J. Fritzsche K. et al.

Assessment of the structured clinical interview (SCID) for DSM-5 for somatic symptom disorder in general hospital outpatient clinics in China.

BMC Psychiatry. 21: 144

Dimensions of hypochondriasis.

Br J Psychiatry. 113: 89-93Welch P.G. Carleton R.N. Asmundson G.J.G.

Measuring health anxiety: moving past the dichotomous response option of the original whiteley index.

J Anxiety Disord. 23: 1002-1007Salkovskis P. Rimes K.A. Warwick H.M.C. et al.

The health anxiety inventory: Development and validation of scales for the measurement of health anxiety and hypochondriasis.

Psychol Med. 32: 843-853Hedman E. Lekander M. Ljótsson B. et al.

Optimal cut-off points on the Health Anxiety Inventory, Illness Attitude Scales and Whiteley Index to identify severe health anxiety.

PLoS One. 10: e0123412Hiller W. Rief W. Fichter M.M.

Dimensional and categorical approaches to hypochondriasis.

Psychol Med. 32: 707-718Abramowitz J.S. Olatunji B.O. Deacon B.J.

Health anxiety, hypochondriasis, and the anxiety disorders.

Behav Ther. 38: 86-94Alberts N.M. Hadjistavropoulos H.D. Jones S.L. et al.

The short health anxiety inventory: a systematic review and meta-analysis.

J Anxiety Disord. 27: 68-78Greeven A. Spinhoven P. van Balkom A.J.L.M.

Hypochondriasis Y-BOCS: a study of the psychometric properties of a clinician-administered semi-structured interview to assess hypochondriacal thoughts and behaviours.

Clin Psychol Psychother. 16: 431-443Toussaint A. Hüsing P. Kohlmann S. et al.

Detecting DSM-5 somatic symptom disorder: criterion validity of the Patient Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Scale-8 (SSS-8) in combination with the Somatic Symptom Disorder – B Criteria Scale (SSD-12).

Psychol Med. 50: 324-333Kroenke K. Spitzer R.L. Williams J.B.W.

The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms.

Psychosom Med. 64: 258-266Gierk B. Kohlmann S. Toussaint A. et al.

Assessing somatic symptom burden: a psychometric comparison of the Patient Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Scale-8 (SSS-8).

J Psychosom Res. 78: 352-355Toussaint A. Murray A.M. Voigt K. et al.

Development and validation of the somatic symptom disorder-B criteria scale (SSD-12).

Psychosom Med. 78: 5-12Laferton J.A.C. Stenzel N.M. Rief W. et al.

Screening for DSM-5 somatic symptom disorder: diagnostic accuracy of self-report measures within a population sample.

Psychosom Med. 79: 974-981Gierk B. Kohlmann S. Kroenke K. et al.

The somatic symptom scale–8 (SSS-8).

JAMA Intern Med. 174: 399Toussaint A. Löwe B. Brähler E. et al.

The somatic symptom disorder - B criteria scale (SSD-12): factorial structure, validity and population-based norms.

J Psychosom Res. 97: 9-17

Psychological Mechanisms of medically unexplained symptoms: an integrative conceptual model.

Psychol Bull. 130: 793-812Warwick H.M.C. Salkovskis P.

Hypochondriasis.

Behav Res Ther. 28: 105-117

Hypochondriasis and somatosensory amplification.

Br J Psychiatry. 157: 404-409Shi C. Taylor S. Witthöft M. et al.

Attentional bias toward health-threat in health anxiety: a systematic review and three-level meta-analysis.

Psychol Med. : 1-10Witthöft M. Kerstner T. Ofer J. et al.

Cognitive biases in pathological health anxiety.

Clin Psychol Sci. 4: 464-479Van den Bergh O. Witthöft M. Petersen S. et al.

Symptoms and the body: taking the inferential leap.

Neurosci Biobehav Rev. 74: 185-203Van den Bergh O. Winters W. Devriese S. et al.

Learning subjective health complaints.

Scand J Psychol. 43: 147-152Vlaeyen J.W.S. Crombez G. Linton S.J.

The fear-avoidance model of pain.

Pain. 157: 1588-1589Carson A. Ludwig L. Welch K.

Psychologic theories in functional neurologic disorders.

Handb Clin Neurol. 139: 105-120Olatunji B.O. Etzel E.N. Tomarken A.J. et al.

The effects of safety behaviors on health anxiety: an experimental investigation.

Behav Res Ther. 49: 719-728Schenk H.M. Bos E.H. Slaets J.P.J. et al.

Differential association between affect and somatic symptoms at the between- and within-individual level.

Br J Health Psychol. 22: 270-280Görgen S.M. Hiller W. Witthöft M.

Health anxiety, cognitive coping, and emotion regulation: A latent variable approach.

Int J Behav Med. 21: 364-374Okur Güney Z.E. Sattel H. Witthöft M. et al.

Emotion regulation in patients with somatic symptom and related disorders: A systematic review.

PLoS One. 14: e0217277Schnabel K. Petzke T.M. Witthöft M.

The emotion regulation process in somatic symptom disorders and related conditions - A systematic narrative review.

Clin Psychol Rev. : 102196Schnabel K. Schulz S.M. Witthöft M.

Emotional reactivity, emotion regulation, and regulatory choice in somatic symptom disorder.

Psychosom Med. 84: 1077-1086

Psychobiological perspectives on somatoform disorders.

Psychoneuroendocrinology. 30: 996-1002Axelsson E. Hedman-Lagerlöf E.

Cognitive behavior therapy for health anxiety: Systematic review and meta-analysis of clinical efficacy and health economic outcomes.

Expert Rev Pharmacoecon Outcomes Res. 19: 663-676Cooper K. Gregory J.D. Walker I. et al.

Cognitive behaviour therapy for health anxiety: a systematic review and meta-analysis.

Behav Cogn Psychother. 45: 110-123Olatunji B.O. Kauffman B.Y. Meltzer S. et al.

Cognitive-behavioral therapy for hypochondriasis/health anxiety: a meta-analysis of treatment outcome and moderators.

Behav Res Ther. 47: 33-41Kleinstäuber M. Witthöft M. Hiller W.

Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis.

Clin Psychol Rev. 31: 146-160van Dessel N. den Boeft M. van der Wouden J.C. et al.

Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults.

Cochrane Database Syst Rev. Creed F. Henningsen P. Fink P. Medically unexplained symptoms, somatisation, and bodily distress : developing better clinical services. 1st edition. Cambridge University Press, CambridgeThe clinician’s guide to treating health anxiety : diagnosis, mechanisms, and effective treatment. 1st edition. Academic Press, LondonWeck F. Neng J.M.B.B. Richtberg S. et al.

Cognitive therapy versus exposure therapy for hypochondriasis (health anxiety): a randomized controlled trial.

J Consult Clin Psychol. 83: 665-676Myers L. Sarudiansky M. Korman G. et al.

Using evidence-based psychotherapy to tailor treatment for patients with functional neurological disorders.

Epilepsy Behav Reports. 16: 100478Liu J. Gill N.S. Teodorczuk A. et al.

The efficacy of cognitive behavioural therapy in somatoform disorders and medically unexplained physical symptoms: A meta-analysis of randomized controlled trials.

J Affect Disord. 245: 98-112Greeven A. van Balkom A.J.L.M. Visser S. et al.

Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial.

Am J Psychiatry. 164: 91-99Fallon B.A. Ahern D.K. Pavlicova M. et al.

A randomized controlled trial of medication and cognitive-behavioral therapy for hypochondriasis.

Am J Psychiatry. 174: 756-764Schweitzer P.J. Zafar U. Pavlicova M. et al.

Long-term follow-up of hypochondriasis after selective serotonin reuptake inhibitor treatment.

J Clin Psychopharmacol. 31: 365-368Kleinstäuber M. Witthöft M. Steffanowski A. et al.

Pharmacological interventions for somatoform disorders in adults.

Cochrane Database Syst Rev.